Iaso Therapeutics

East Lansing, MI · Founded 2018 · Privately Held (backing)

Operator of synthetic antigen-based vaccines designed to prevent and treat infectious diseases. Iaso Therapeutics is based in East Lansing, MI and was founded in 2018. Its last reported valuation was $5.3 million in Jan 2023. It has raised $1.8 million across 2 recorded rounds; the latest was a $570,000 seed round in Jan 2026.

Last reported valuation
$5.3M
Oct 2026
Priced at
—
Total raised
$1.8M
Last round
Seed Round
Jan 2026
What is Iaso Therapeutics worth?
$5.3Mlast reported valuation · Oct 2026

Iaso Therapeutics's last reported valuation, Jan 2023. Nothing priced has surfaced since.

Free account
More of Iaso Therapeutics with a free account
  • ·Watch Iaso Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Iaso Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Jan 2026Seed Round$570K▮
Dec 2022Seed Round$438K▮
Unlock post-money valuations

Membership and data by Private Market View

Iaso Therapeutics valuation

Iaso Therapeutics's last reported valuation was $5.3 million in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Iaso Therapeutics raised?

Iaso Therapeutics has raised $1.8 million in total; 2 of its rounds are on record. The largest on record was a $570,000 seed round in Jan 2026.

Iaso Therapeutics has filed 1 Form D with the SEC, most recently in Jan 2023 ($437,850 sold to 5 investors).

How Iaso Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Iaso Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Iaso Therapeutics

What is Iaso Therapeutics worth?
Iaso Therapeutics is valued at $5.3M as of Oct 2026. Iaso Therapeutics's last reported valuation, Jan 2023. Nothing priced has surfaced since.
How much has Iaso Therapeutics raised?
Iaso Therapeutics has raised $1.8M in total funding across 2 recorded rounds.
When did Iaso Therapeutics last raise?
Iaso Therapeutics last raised in Jan 2026 (Seed Round), raising $570K.